Clinical Trial Update: Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC [Phase 1]

View source ↗

Summary

This document describes an ongoing Phase 1 trial evaluating RYZ101 in combination with standard of care for somatostatin receptor-positive extensive-stage small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• RYZ101

Snippet

Sponsor: RayzeBio, Inc. | Conditions: SCLC,Extensive Stage | Phase 1 | Status: ACTIVE_NOT_RECRUITING